Hosted on MSN18d
Innate immune training aggravates inflammatory bone loss in experimental models
Now, researchers from Penn's School of Dental Medicine and international collaborators have investigated the effects of training the innate immune system in experimental models of two chronic ...
Yahoo Finance29d
Innate Pharma Announces U.S. FDA Granted Breakthrough Therapy Designation to Lacutamab for Relapsed or Refractory Sézary Syndrome
adding to a Fast Track designation by the U.S. FDA received in 2019 as well as a PRIME designation by European Medicines Agency in 2020 Innate continues to align with regulatory agencies around ...
Business Wire19d
Innate Pharma to Participate in the 2025 Leerink Partners Global Healthcare Conference
MARSEILLE, France--(BUSINESS WIRE)--Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that members of its executive team ...
MarketWatch27d
Innate Pharma Shares Rise After Breakthrough Therapy Designation for Lacutamab
Innate Pharma shares were up 16% to $2.25 after the company said the Food and Drug Administration has granted Breakthrough Therapy Designation to lacutamab for the treatment of adult patients with ...